RET and neoplasm: For example, if there were age-related changes in expression of one of the genes to which the RET tyrosine kinase domain can be rearranged, this could affect the likelihood of that particular rearrangement leading to a clinically detectable tumour, possibly through affecting the chance of acquiring the additional mutations needed to progress to a clinically detectable tumour in an age-related fashion.